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SUMMARY.-Sixteen groups, each of 50 Swiss female SPF mice, were treated
thrice weekly with various combinations of 3,4-benzopyrene (BP) and/or the
neutral fraction of cigarette smoke (NF) in acetone applied to the skin. Some
groups received one carcinogen, some the other and some a mixture of the
two. Skin tumour incidence rates were found to increase both with the dose
of NF and with the dose of BP. With BP alone a threshold dose was found
beyond which a very heavy incidence rate of malignant skin tumours occurred.
After correction ofthe results for intercurrent deaths it was found that when NF
and BP are applied together as a mixture they do not act independently in the
production of malignant skin tumours but interact positively. This suggests
that some ofthe components of NF act as cocarcinogens ratherthan as complete
carcinogens. Treatment with NF appeared to increase the incidence of malig-
nant lymphomas. The data were not suitable for deciding whether the various
treatments influenced the rates of incidence of internal tumours of other types,
for example, lung tumours.
THE repeated application of cigarette smoke condensate to the skin of mice
or rabbits may induce benign and malignant epithelial tumours. The type of
tobacco, the way it is cut and packed into cigarettes, the conditions of smoking,
the freshness of the condensate at the time of its application to the test animals,
the dose of condensate applied, and the strain of test animal are amongst many
factors that are known to influence the time and rate of appearance of skin
tumours. Nevertheless, provided the test species is sufficiently sensitive and the
dose ofcondensate applied is sufficiently high, positive results are obtained despite
wide variations in the other conditions mentioned (for review, see Wynder and
Hoffmann, 1967).
Tobacco smoke condensate has been chemically fractionated by a number of
different methods and the resultant fractions tested separately for carcinogenicity,
mainly by the method of repeated application to mouse skin. A consistent
finding in these tests, irrespective of the fractionation technique, has been that
the major part of the carcinogenic activity of the whole smoke condensate can
be accounted for bythe activity ofaneutral fraction that remains afterremoval of
carboxylic acids, phenols and bases, including the nicotine alkaloids.
In the neutral fraction, several polynuclear aromatic hydrocarbons (PAH),
known to be potent carcinogens, have been identified (Kennaway and Lindsey,
1958; Wynder and Hoffmann, 1963), but it is unlikely that the carcinogenic
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far been identified in it. Possibly, constituents of the neutral fraction other
than PAH contribute to its carcinogenicity, either by acting as complete carcino-
gens or as co-carcinogens.
Roe et al. (1959) showed that the phenolic fraction of tobacco smoke con-
densate, which on its own has little or no tumorigenic effect, could promote skin
tumour formation in mice pretreated with a subcarcinogenic dose of 7,12-di-
methylbenz(a)anthracene. They suggested that the carcinogenicity of the whole
condensate maybe due tothe combined effect ofcarcinogens (probably ofthe PAH
type) and cocarcinogens, such as phenols. Wynder and Hoffmann (1961) con-
firmed these findings. Later, Bock et al. (1962, 1965a, 1965b) reported that the
heptane-soluble components ofwhole smoke condensate which, according to them,
would not include the phenolic constituents, possessed higher carcinogenic activity
than did the smoke condensate itself. They felt that their data conflicted with
the view that phenols played a role in the carcinogenicity of smoke condensates.
More force was given to the suggestion that cocarcinogens in the condensate were
ofimportance by the finding ofRoe (1962) that carcinogenicity of a low concentra-
tion of 3,4-benzopyrene may be greatly enhanced if tobacco smoke condensate is
applied simultaneously. However, neither this finding, nor that of Gellhorn
(1958) could be regarded as conclusive evidence of carcinogen-cocarcinogen inter-
action, since in neither case were there adequate dose-response data for BP alone
or for smoke condensate alone.
The discovery that certain straight chain aliphatic compounds, in particular
dodecane, may act as cocarcinogens (Horton et al., 1957; Shubik and Saffiotti,
1962) opened up a further possibility, namely that the carcinogenicity of the
neutral fraction ofsmoke condensate for mouse skin may itselfbe due to the com-
bined action of carcinogens and cocarcinogens. The experiment described in the
present paper was designed to investigate this possibility. The actual plan,
however, depended on the assumption that, if the neutral fraction of tobacco
smoke contains cocarcinogens, their concentration is such that they would en-
hance the activity not only of carcinogens present in the neutral fraction, but also
of further carcinogens added to the neutral fraction. The plan involved an
evaluation of the carcinogenicity for mouse-skin of combinations of NF and BP
at various concentrations in the light of dose-response data for BP alone and NF
alone.
MATERIALS AND METHODS
Mice
Eight hundred female Swiss mice were kindly supplied to us by Dr. D. G.
Davey ofImperial Chemicals Limited. These animals were born and reared under
barrier conditions and were free of specified pathogens (SPF) up to the age of
6 weeks when they were transferred to our experimental unit.
The latter consisted ofa separate vermin-proofroom in which no other animals
were kept. However, there were no facilities for sterilization of food or of the
wood-shavings provided as bedding. In other words, from the age of 6 weeks
onwards the animals were kept under clean conventional conditions.
During the experiment mice were housed in macralon boxes, 10 per box, and
provided with cubed Diet 41B (Messrs. Dixon, Ware, Herts.) and water ad
libitum.
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On arrival in our unit, at the age of 6 weeks, all mice were vaccinated with
sheep lymph on the tail as a precaution against ectromelia. Mice in each cage
were rendered distinguishable from each other by a system of holes and notches
punched on the ears-but this was not done until skin tumours began to appear
(i.e. approximately 30 weeks). Mice were, on average, 91 weeks old at the start
of treatment.
Neutral Fraction (NF) of cigarette smoke condensate
This was most kindly provided by Dr. Whitehead, Harrogate Laboratories,
Tobacco Research Council. It was prepared by the smoking of standard 70 mm.
long and 25-3 mm. circumference cigarettes of the types, and in the proportions,
representative of those of the main brands sold on the British market.
The cigarettes were smoked in automatic smoking machines set to collect 25 ml.
smoke in 2 seconds once every minute, and to smoke cigarettes down to a butt
length of 20 mm. Smoke was condensed in a series of four glass traps cooled by
acetone and crushed solid carbon dioxide. The condensate was washed from the
traps by acetone at room temperature and the washings were filtered through
glass wool (for details, see Day, 1967).
The NF was prepared from the whole smoke condensate as follows: smoke
condensate in acetone as derived from the traps was mixed with diethyl ether
(redistilled peroxide-free either from which fluorescent material had been removed
by treatment with sodium) and 2N hydrochloric acid. After removal of the
aqueous layer, and further similar extractions with hydrochloric acid, the ether
solution was repeatedly extracted with 30/ w/v aqueous potassium hydroxide
solution. Following the final extraction, the ether solution was dried with an-
hydrous magnesium sulphate, filtered, andthe etherremoved in arotary evaporator
(for full details, see Day, 1967).
Batches of NF were sent at 2-week intervals from Harrogate to this Institute
and, apart from a period of up to 6 hours in transit, the material was stored at
0-4° C. between production and use. The interval between production and use
was kept as short as possible and rarely exceeded 3 weeks.
3,4-Benzopyrene (BP) was obtained from L. Light and Company, and Acetoine
(Analar Grade) from Messrs. Hopkins and Williams.
Preparation of solutions for application to mice
Treatment consisted of the repeated application to the dorsal skin of acetone
solutions which contained NF alone, BP alone, or both NF and BP in a variety of
combinations. Once every 2 weeks, solutions of NF were prepared by weighing
appropriate amounts of NF into ground-glass-stoppered amber bottles and
adding acetone so that the dose of NF required for each animal in a particular
experimental group was contained in 025 ml. Measured amounts of a standard
BP/acetone solution were added to the NF before addition of acetone where
appropriate. Solutions ofBP at various concentrations were prepared by dilution
of the standard solution with further acetone. All solutions were kept in a refri-
gerator at 0-40 C. until used.
Application of solutions to mice
At the start of the experiment and thereafter at approximately weekly inter-
vals hair was removed from the entire dorsum of each mouse by electric clippers
lubricated with liquid paraffin BPC.
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Solutions were delivered on to the clipped area from calibrated pipettes in
such a way that they spread out over more or less the whole of the clipped area.
Examination of micefor skin tumour development and other lesions
Mice were carefully examined at fortnightly intervals for the development of
skin tumours, and on each occasion the number of tumours, the site and size of
each tumour, and their apparent benignity or malignancy were recorded.
In addition, records were made both at the times of the fortnightly examina-
tions and at other times of the state of general health of individual mice and of
other conditions.
Until the end ofthe 93rd week ofpainting, mice werekept under treatment and
observation unless they were noticeably sick and thought unlikely to survive for
more than a few days. Such mice were killed. The experiment was terminated
at 93 weeks and all the animals killed and examined post mortem during the
following 3 weeks.
Removal ofmalignant skin tumours at operation
Skin tumours considered, on the basis oftheir macroscopic appearances, to be
malignant were removed under ether anaesthesia. It was thought that after
operation such animals could be returned to the experiment and be at risk of
developing further skin tumours, including further malignant tumours; however,
because of difficulties in interpretation, it was later decided to ignore information
with regard to skin tumours obtained subsequent to the removal of a malignant
tumour by biopsy.
Ninety-four such operations were carried out on 73 different mice. In 77
instances the macroscopic diagnosis was confirmed histologically, in a further
9 the lesion wasregarded as" probably malignant " (see below), and inthe remain-
ing 8 instances the tumour removed was histologically benign (see Table I).
TABLE I.-Accuracy of Macroscopic Diagnosis of Malignancy in Relation to Skin
Tumours
No. of mice No. of
Treatment from which mice Histological report
to skin presumed subjected Total A
(thrice weekly) malignant skin to more number of Malig- Tumour
tumours were than one skin nancy designated Tumour
NF BP removed such biopsy con- " probably designated
Group (mg.) (pg.) surgically operation operations firmed malignant" "benign"
1 .80 -. 5 . 1 . 6 . 5 1 0
2 .40 . 4 . 1 . 5 . 4 0 1
3 .20 -. 4 . 2 . 6 . 4 1 1
4 . 9 . 22 . 9 . 35 . 28 5 2
5 . 3 . 4 . 1 . 5 . 4 0 1
6 .- 1 . 0
7 . 0-3 0
8 . 0.1 . 0
9 .40 3 . 9 . 0 . 9 . 8 1 0
10 .40 1 . 4 . 0 4 . 4 0 0
11 .40 0 3. 5 . 1 6 . 5 0 1
12 .20 3 . 10 . 1 . 12 . 10 1 1
13 .20.1 . 4 . 0 . 4 . 3 0 1
14 .20 0-3. 2 . 0 2 . 2 0 0
15 . Acetone only. 0
16 . None . 0
Totals. . 73 . 16 . 94 . 77 9 8
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Seven other animals were operated upon during the experiment: 3 to confirm
a macroscopic diagnosis of inflammatory ulceration of the skin, 1 to confirm a
diagnosis of malignant lymphoma, and 3 to remove neoplasms other than epi-
theliomas-a haemangiosarcoma from the tail, a subcutaneous sarcoma, and a
mammary adenocarcinoma.
Pathological observations
All except 15 ofthe 800 mice were subjected to systemic post mortem examina-
tion (Roe, 1965). In most cases mice were killed when seento be sick, but approxi-
mately 10% were found dead and ofthese 14 were too decomposed for meaningful
autopsy. One mouse was lost.
All skin tumours thought to be malignant or possibly malignant, all lesions of
tissues other than the skin thought to be neoplastic, and a variety of apparently
non-neoplastic lesions were submitted to histological examination. Tissues were
fixed in Bouin's solution, cut at 5 ,u and stained with haematoxylin and eosin.
Various other stains were used where indicated.
Histopathological criteriafor malignancy ofskin tumours
Invasion or penetration of the panniculus carnosus muscle was taken as the
main criterion of malignancy. Lesions that appeared cytologically malignant, or
showed invasion of the dermal collagen, were classified as " probably malignant "
if they had not reached the level of the panniculus muscle. In practice only a
few lesions fell into this category and for the purposes of evaluating the present
experiment they were regarded as benign.
Since a skin tumour grows from a microscopic lesion to a large mass over a
period of some weeks, it was necessary to define the " time of occurrence " of a
skin tumour in such a way that observer variability was reduced to a minimum.
A malignant tumour was defined to " occur " when it first reached a diameter of
10 mm. Experience has shown that, although a mouse normally lives for up to
several weeks after it first has a 10 mm. malignant tumour, it is uncommon for a
tumour ofthis size, if it has the macroscopic characteristics of malignancy, not to
show invasion of the panniculus muscle. A benign tumour was defined as any
lump which persisted with a diameter of 2 mm. or more for 2 weeks or more;
its " time of occurrence " was the second week.
Design of experiment
Mice were allocated non-selectively to 16 equivalent groups, each of 50.
Groups 1, 2 and 3 were given, respectively, 80 mg., 40 mg. and 20 mg. NF in
0-25 ml. acetone thrice weekly by application to the dorsal skin. It was hoped
from the results obtained in these 3 groups to obtain information on the relation
between skin tumour response and dose of NF.
Groups 4-8 were given, respectively, thrice weekly applications of 9 ,ug.,
3 ,ug., 1 ,ug., 0 3 jag. and 0-1 jag. BP in 0-25 ml. acetone to the dorsal skin. From
the results obtained in these 5 groups information on the relation between skin
tumour response and dose of BP was hoped for.
Groups 9-11 were given, respectively, the following mixtures of NF and BP:
40 mg. NF + 3 jag. BP, 40 mg. NF + 1 ,ug. BP and 40 mg. NF + 0-3 jg. BP.
These mixtures were applied thrice weekly in 0-25 ml. acetone. Groups 12-14
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were also treated with mixtures ofNF and BP in acetone but at the concentrations:
20 mg. NF + 3 ,ug. BP, 20 mg. NF + 1 4ag. BP and 20 mg. NF + 0 3 ,ug. BP,
respectively. It was hoped from observations on these 6 groups to learn whether
the effects of NF and BP, mixed together, were additive or less or more than
additive as judged against the background of dose-response information gleaned
from observations on Groups 1-8.
Mice ofgroup 15 weretreatedthriceweekly with 0-25 ml. acetoneonlyandthose
of group 16 were clipped, as other groups, but left untreated.
For convenience, the details of treatment are summarized in columns 2 and 3
of Tables I, III and IV.
Method ofanalysis
Each mouse is subject to several competing causes of death (or elimination
fromthepopulation atrisk)-the occurrence ofskintumours, deathfrommalignant
lymphoma, death from various other tumours and death from non-malignant
causes. The analysis of any one cause of death is complicated by the loss of
mice from other causes. For any one mouse, the period ofexposure to risk starts
at the time offirst treatment and is ended by death. The methodology involved
in the separation and study ofeach particular cause ofdeath is actuarial (Pike and
Roe, 1963; Peto and Peto, 1971). The actuarial survival curve, whose value at
time after first treatment t we denote by h(t), is calculated for the particular cause
of death being studied. This survival curve is based on the pooled experience
of all 800 mice in all the 14 treatment groups. A mouse may either die from
the particular cause of death being studied (in which case the observed " inci-
dence " 1) or from some other cause of death (observed " incidence " 0);
in other words the observed incidence for each mouse can only be 1 or 0. If the
time for which a particular mouse lived and was at risk is t then the " expected
incidence " for that mouse is defined as -loge h(t). This quantity gets bigger as
t increases, i.e. the "expected incidence" for mice with longer lives is bigger
than that for mice with shorter lives-and it is zero for mice with very short lives.
For the mice ofeach treatment group we now sum the observed and the expected
incidences. If for a particular group the sum of the observed incidences is 0
and the sum ofthe expected incidences is E, and ifthere is no connection between
group membership and risk from the particular cause ofdeath being studied, then
the values of0 and E for each group will differ only as a result ofrandom fluctua-
tions and the sum over all groups of (O - E)2/E will have a chi-squared distribu-
tion. Ifthe sum of (0 - E)2/E is significantly too big, indicating that the treat-
ments influence the risk from the particular cause of death being analysed, then
we proceed to examine the relative incidence rate, O/E, for each group to pin-
point the treatments responsible for the differences.
RESULTS
By the maintenance ofvigilance on 7 days ofeach week throughout the 2 year
experimental period, it was possible to make a full post-mortem examination and
histopathological evaluation on 785 out of the 800 mice in the experiment.
Because of this, it is of interest and value to discuss aspects of the results other
than skin tumour induction. A minor feature of less favourable significance is
that early in the experiment (during the 28th week) one mouse of group 5 by
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means ofhiding in an apparently empty box took it upon herself to join group 6.
As at that time mice had not been individually numbered the migrant could not
be distinguished from her new colleagues and had, thereafter, to be regarded as
one of them.
The mainfeature ofinterest intheresults isthe analysis ofthe crop ofmalignant
skin tumours to see whether the neutral fraction seemed to act as a cocarcinogen
to benzopyrene or whether the two treatments acted independently. However,
it is also ofinterest to see whether the various carcinogens painted on to the skin
induced neoplasms at other sites, and we have examined malignant lymphomas,
lung tumours and various tumours of other sites to see if their incidence rates
varied with treatment.
We have also studied the shapes of the dose/response curves for malignant
skin tumours in which the relative incidence rates, O/E, are plotted against the
dose of carcinogen; it has been suggested (e.g. by Pike and Doll, 1965) that one
should be proportional to the other and this hypothesis has been examined criti-
cally.
TABLE II.-Observed and (Actuarially) Expected Numbers of Deathsfrom all Causes
other than Neoplasms
NF dose (mg. x 3 weekly)
0 20 40 80
41 19 17 13
0
44.71 15*40 14*00 11-83
23
1
22 .74
22 18 10
21-00 14-03 13-24
17 9 16
1
20-90 17*58 11-05
18 12 13
3
19-48 10*62 12-84
13
9
11-59
Key
observed
expected
Although the mean durations of survival in the low-dose groups were on the
whole greater than in the high-dose groups this was only due to the killing of mice
by various neoplasms in the high-dose groups: when the deaths due to non-
malignant causes were examined the rates in all 16 groups were found to be very
similar. Table II, based on Fig. 1, compares the observed numbers of deaths
from causes other than neoplasms with the numbers that would be expected after
0
x
-
0
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FIG. 1.-Actuarial survival curve for non-neoplastic deaths.
actuarial allowance for duration of time at risk. No evidence of inhomogeneity
is revealed (X2 = 11.5, indicating that the death rates from non-neoplastic
causes do not vary between groups).
Skin tumour incidence
The cumulative totals of mice in the 16 groups with one or more skin tumours
at times ranging from 200 to 700 days are shown in Table III, and the cumulative
TABLE III.-Survival (from Start of Treatment) and Development ofSkin Tumours
(Benign and Malignant)
Treatment to skin
(thrice weekly in
0 25 ml. acetone)
A_ Cumulative number of mice with skin tumours/
3,4- survivors Total no. of
Neutral benzo- No. A_ skin tumours
fraction pyrene of 200 300 400 500 600 700 in all mice
Group (mg.) (pg.) mice Days Days Days Days Days Days ofgroupt
1 80 - . 50 . 0/44 2/41 11/32 17/17 23/8 24/0. 56
2 40 50 . 1/48 4/45 11/37 16/23 21/8 23/0. 46
3 20 . 50 . 0/47 2/43 7/35 11/22 15/12 15/0. 22
4 . 9 . 50 . 0/46 4/40 21/32 28/21 33/8 34/0. 144
5 3 . 49* . 0/47 0/41 1/37 7/35 8/24 8/0. 22
6 . 1 . 51* .0/48 0/43 0/37 1/30 1/18 1/0. 1
7 . 0-3 . 50 . 0/46 0/42 0/37 0/30 0/19 0/0. 0
8 . 0.1 . 50 . 0/45 1/42 1/35 1/31 1/22 1/0. 1
9 . 40 3 . 50 . 1/45 3/35 12/30 21/19 25/5 25/0. 67
10 . 40 1 . 50 . 0/47 5/37 9/32 17/17 20/4 21/0. 64
11 . 40 0*3 . 50 . 0/48 3/44 7/36 14/22 17/5 19/0. 39
12 . 20 3 50 0/46 3/40 22/35 26/13 29/4 30/0. 83
13 . 20 1 . 50 0/49 5/46 13/38 22/24 26/15 27/0. 54
14 . 20 0-3 . 50 0/44 2/41 7/35 10/22 14/12 16/0. 29
15 Acetone only . 50 0/49 0/47 0/45 0/37 0/23 0/0 . 0
16 . No treatment . 50 . 0/48 0/43 0/40 0/31 0/21 0/0 . 0
Totals 800 2/747 34/670 122/573 191/394 233/208 244/0 . 628
* During the 28th week of treatment one mouse from group 5 accidentally became mixed with,
and indistinguishable from, mice of group 6.
t The totals in this column cannot be meaningfully compared because of differences in survival
between groups. However, they are included because they suggest that multiplicity ofskin tumours
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totals of malignant skin tumours at the same time appear in Table IV. As can
be seen, the crop of malignant tumours appeared on average much later than the
crop ofbenign tumours. The total numbers oftumours that developed in a group
can be a misleading indicator of the incidence rate experienced by that group
until it has been divided by the appropriate expected number. The observed
and expected numbers of malignant skin tumours appear in Table V(a), and the
relative incidence rates (with approximate standard errors) in Table V(b). The
dependence ofresponse on dose is very striking; an increase ofincidence rate with
TABLE IV.-Development of Malignant Skin Tumours
No. of
Treatment to skin No. of mice
(thrice weekly in mice with
0 25ml. acetone) that more No. of
developed Cumulative number of mice at various than mice
3,4- 1 or more times after start of treatment 1 malig- with
Neutral Benzo- malignant, A ,- nant meta-
fraction pyrene skin 200 300 400 500 600 700 skin static
Group (mg.) (,ug.) tumours Days Days Days Days Days Days tumour deposits
1 . 80 - . 9 .0 0 1 5 8 9. 0 . 5
2 . 40 - . 8 .0 1 2 4 7 8. 2 . 1
3 . 20 . 3 .0 0 0 1 3 3. 0 . 2
4 . - 9 . 31 .0 1 9 20 28 31. 14 . 6
5 - 3 . 4 .0 0 1 3 4 4. 1 . 0
6 . - 1 . 0 .0 0 0 0 0 0. 0 . 0
7 . - 0 3. 0 .0 0 0 0 0 0. 0 . 0
8 . - 0.1. 0 .0 0 0 0 0 0. 0 . 0
9 . 40 3 . 15 .0 1 2 6 14 15. 3 . 2
10 . 40 1 . 11 .0 0 3 5 9 11. 2 . 2
11 . 40 0 3. 7 .0 1 3 3 5 7. 1 . 2
12 . 20 3 . 12 .0 1 4 8 11 12. 4 . 6
13 . 20 1 . 8 .0 0 0 4 7 8. 1 . 1
14 . 20 0 3. 6 .0 2 2 3 6 6. 0 . 1
15 .Acetone only. 0 .0 0 0 0 0 0. 0 . 0
16 .No treatment. 0 .0 0 0 0 0 0. 0 . 0
Totals .114 .0 7 27 62 102 114. 28 . 28
dose ofNF can be seen within each BP dose level and an increase ofresponse with
dose of BP can be seen within each NF dose level (see Fig. 2-8 and Table V(b)).
Two questions can be asked of Table V(b):
1. Are the incidence rates for NF and BP alone proportional to the doses
given?
2. Do the carcinogens act independently? i.e. can we postulate a set of rates
for the pure NF and pure BP groups such that the rate for a mixed group is
the sum of the corresponding two rates for the separate components?
The answer to the first question is clearly negative; although the rates for
the various pure doses ofNF seem to increase by about 04 for every 20 mg. dose,
the rates for BP are definitely non-linear with a threshold, beyond which a very
strong response occurs, somewhere between a weekly dose of 3 x 3 jg. and a
weekly dose of 3 x 9 jtg.
The best-fitting constant of proportionality is a rate of 0 33 per 1 ,ug. dose.
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TABLE V(a).-Observed and Expected Numbers of Malignant Skin Tumours in the
14 Groups Treated with NF and/or BP
NF dose (mg. x 3 weekly)
0 20 40 80
0 3 8 9
0
7*96 7.-77 5.97
0
12*73
j 0 6 7 11.71 7.65 6.33
0 8 11
I
11-65 8-99 5*04
4 12 15
3
12*54 4-52 5*50
31
Key
observed
expected
9
5-64
TABLE V(b).-Relative Incidence Rates with Standard Errors for Malignant Skin
Tumours
NF dose (mg. x 3 weekly)
0 20 40 80
0 0 0*40 0 05 1*0 0 0.13 15± 0-25
1 D9 0
I 0 0'8 ± 0*11 1*1 ± 0*17
1 0 0*9 ± 0-12 2-2 ± 0*44
3 0.3 ± 0.03 2*7 ± 0-61 2-7 ± 0-49
9 5-5 ± 0-98
VI.-Expected Numbers of Malignant
Obtains
Dose of BP Observed number of
x 3 weekly skin malignancies
0 . 0
0 * * 0
1 . 0
3 . 4
9 31
Skin Tumours if Proportionality
Expected number of
skin malignancies
0
05
i1*3
3.9
12-5
* 16*9
1-
x
b
0
0
cc
(D x
0
TABLE
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FIG. 8.-Effect of BP on induction of malignant skin tinours by 20 mg NF applied
thrice weekly (groups 12 and 13 with groups 3 and 14 combined).
These predicted and observed numbers are seriously discrepant (x = 23'3:
P <c 0-001) and so the resp-onse to BP is not proportional to the dose of BP.
It is interesting to note that Wynder et at. (1957) and Poel (1959) have reported
data on response to various doses of BP which seem to exhibit a similarly placed
threshold of dose.
The answer to the second question is also negative. Ifwe choose the marginal
rates to maximize the likelihood ofour data, we get for 20 mg. NF and 40 mg. NF
alone the incidence rates 0-825 and 1-492 respectively. For 3 ugg. ofBP alone we
get the rate 0-586 andfor lower doses ofBP alone we get zero. Basing our predic-
tions on these rates and assuming independent action of the two carcinogens we
would predict the numbers of malignant skin tumours set out in Table VII.
TABLE VII.-Expected Number& of Malignant Skin Tumours if Independence
Obtaitn8
Dose of NF (mg. x weekly)
0 20 40
X cc ee1l=
bt
P4
4-4
0
0
U U 6O57 11i59
1 0 6*31 9*44
1 0 7*41 7-52
3 7*35 6&38 11*44
This leadtothe expectation of28-5 malignant skintumours inthe single-treatment
groups and 48-5 in the mixed-treatment groups; in fact, we observed 15 in the
single-treatment groups and 59 in the two-treatment groups, so it seems that the
mixed-treatments are more than independently additive in their action (x2 = 6x6:
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We have found a non-linear dose/response curve for the carcinogenicity ofBP,
such that a single dose of BP produces a rate of cancer incidence greater than
twice the rate produced by halfthat dose. Our definition ofthe independence of
action of two treatments is such that we would therefore say that the two halves
ofa dose ofBP do not act independently, but together have a more than indepen-
dent effect. Other definitions of " independent action " are possible; for instance,
since 20 mg. of NF has approximately the carcinogenic force of 3 ,Zg. BP and
40 mg. NF has approximately the carcinogenic force of 5 ,tg. BP, we could define
the action of a mixed dose of 20 mg. NF + 3 ,tg. BP to be " independent " if
together they have the effect of the sum of their BP equivalents, i.e. the effect
of 6 ,tg. BP. According to this definition of " independence ", our two-treatment
groups are consistent with the independence ofthe two treatments. These diffi-
culties only arise if one or both of the dose/response curves for the treatment
given separately are non-linear, since if both are linear all definitions of indepen-
dence of action will agree. Our definition was adopted because independence in
our sense is necessary if the carcinogenic effects of the several components of
cigarette smoke are to be simply added up to give the total carcinogenic effect of
cigarette smoke; our findings indicate that no such simple summation is possible.
Incidence of malignant lymphomas
Table VIII summarizes the results in respect ofthe occurrence ofboth genera-
lized and localized lymphomas. The term " generalized malignant lymphoma "
was applied to any condition in which there was widespread involvement of
lymphatic nodes and lymphatic organs, such as the thymus and spleen, by malig-
nant lymphoid cells. A range of conditions fulfilled this definition. Rapidly
growing lymphoblastic lymphomas of thymic origin were seen during the first
200 days of the experiment. In older mice, thymic involvement and cell type
were variable and, although lymphoblastic lymphomas were still seen, slowly
TABLE VIII.-Incidence of Malignant Lymphoma
Treatment to skin
(thrice weekly in
0 25 ml. acetone)
NF BP
Group (mg-) (pig.)
1 . 80
2 . 40
3 . 20
4 . 9
5 - 3
6 . 1
7 . - 0*3
8 . - 0*1
9 . 40 3
10 . 40 1
11 . 40 0*3
12 . 20 3
13 . 20 1
14 . 20 0*3
15 . Acetone only
16 . None
Totals
Lymphoma incidence
In mice In mice In mice
dying dying dying
before 301 to after
300 days 500 days 500 days Total
5/9 5/24 5/17 15/50
1/4 8/21 6/23 15/48
2/7 4/20 5/22 11/49
0/10 3/19 6/21 9/50
2/8 3/6 18/34 23/48
1/8 5/13 10/30 16/51
1/8 1/12 8/30 10/50
3/8 0/9 8/31 11/48
5/14 7/16 13/19 25/49
3/13 6/20 6/17 15/50
3/6 15/22 10/22 28/50
3/10 8/27 4/13 15/50
1/3 8/21 8/23 17/47
5/9 2/19 5/22 12/50
1/3 4/10 7/36 12/49
3/5 2/11 14/30 19/46
39/125 81/270 133/380 252/785
(31.2%) (30.0%) (35.0%) (32.2%)F. J. C. ROE, R. PETO, FRIEDA KEARNS AND DIANA BISHOP
progressive lymphocytic forms of lymphoma became increasingly common with
age. Late in life lymphoid swellings in the thymic region were, in reality, due to
involvement of anterior mediastinal lymph nodes and not to enlargement of the
thymus. Involvement of other organs such as the liver, kidneys and lungs was
also variable. A relatively small proportion ofcases were leukaemic. Altogether
there were 216 cases of generalized lymphoma among the 785 mice examined
post mortem. In addition, 38 examples of what were regarded as localized
lymphomas were encountered. These, too, were heterogeneous in nature. Iso-
lated involvement of the thymus, or a single lymph node or Peyer's patch, or
a solitary deposit of lymphocytic neoplastic tissue in the spleen made up most of
the cases. A total of 15 cases ofThelma Dunn Type A reticulum-cell neoplasms
(Dunn, 1954) were included under the category " localized lymphoma ". These
tumours arose in the walls ofthe uterus or vagina, or in the ovaries, and involved
the liver, and sometimes the spleen, secondarily. In all probability most ofthese
localized lymphomas represented the early stages of what would have become a
generalized disease had the mice lived longer.
In many cases animals were killed because ofa thymic tumour, enlargement of
cervical, axillary andinguinal lymph nodes, or because ofpoor conditiondue tothe
lymphoma. However, in a few instances the lymphomatous condition was
discovered incidentally in an animal killed for some other reason, e.g. inoperable
skin cancer.
Where the first manifestation of malignant lymphoma was enlargement of
peripheral lymph nodes, the rate of progression of the disease was variable. In
some cases the animals' health failed rapidiy after the enlargement was first
TABLE IX.-Numbers of Cases of Malignant Lymphoma Observed Compared with
Numbers Expected after Adju8tmentfor Survival Differences
NF dose (mg. x 3 weekly)
0 20 40 80
P-4
I" 0
x
bD
0
o
31 11 15 15
0
46*91 14*71 13*36 10*38
11
23 98
10 12 28
21 76 13*70 11-48
16 17 15
1
21*29 15*88 9-34
23 15 25
3
21-24 8*54 10*45
~~~~~~~~~~l I~~~~~~~~~~~~~~~~~~~~~~~~~ 9
9
9-98
Key
observed
expected
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noticed, in others animals remained reasonably fit for several weeks during which
period the nodes slowly enlarged.
For the purpose ofstatistical analysis, all types oflymphoma were regarded as
a single species.
Table IX shows a comparison of the observed numbers of cases of malignant
lymphoma with the numbers expected after survival differences have been taken
into account. There is definite evidence of heterogeneity between observed and
expected numbers (X12 = 77-9: P < 0.001), and examination of Table IX shows
that it is mainly the NF which is producing the excess of malignant lymphomas.
Because some of these lymphomas were discovered earlier than they would
otherwise havebeeninmicethatdiedfrom other causes (particularlyskintumours)
the expected incidences in Table IX should be treated with some caution. How-
ever, we believe that bias from this source, which would tend to inflate the lower
expectations slightly, is unlikely to be substantial since most animals in whom a
malignant lymphoma was found died as a result of that lymphoma and since
malignant lymphomas, once they have reached a big enough size to be detected at
autopsy, are likely to be rapidly lethal.
Lung tumour incidence
Table X summarizes the findings with regard to lung tumours in animals
killed during the periods 0-300 days, 301-500 days and 501-700 days. Only
where the presence of at least one lung tumour was confirmed histologically is an
animal shown inthe table as bearing lung tumours. In some ofthe animals shown
as having multiple lung tumours, not all were examined microscopically. In
each animal the size of the largest lung tumour present was recorded, but this
information is not included in Table X. As expected (Walters, 1966) the average
size of the largest tumour in each mouse increased with the age at death.
As in some previously published experiments (Walters, 1966), lung tumours
were graded in respect of their malignancy. Grade 1 consisted of well-circum-
scribed non-invasive neoplasms. Tumours that showed invasion of surrounding
lung or of airways were put in Grade 2. Tumours that replaced a whole lobe or
had metastasized throughout the lobe in which they arose or other lobes, but had
not spread beyond the visceral pleura were put in Grade 3. Invasion ofthe chest
wall or diaphragm, or metastasis to bronchial lymph nodes were the criteria for
Grade 4 tumours. No case ofmetastasis outside the thorax (Grade 5) was encoun-
tered in the present experiment. Table X shows that in all groups the incidence
of lung tumours, the proportion of animals with more than one lung tumour and
with tumours of the higher grades of malignancy increased with age at death.
In most cases, lung tumours constituted an incidental finding at post mortem
and only in a minority of instances was death attributable to this cause. There-
fore, since lung tumours are slow-growing, their presence or absence in mice killed
for an unrelated reason may not accurately reflect the time-standardized risk of
their development. In other words, the actuarial method of analysis is not
applicable in this case.
Incidence of neoplasms of other types
One hundred and five neoplasms ofother types were encountered. Twenty-six
mice had liver-cell tumours, 20-mammary tumours, 7-ovarian tumours,
9-sarcomas of subcutaneous tissues, 11-haemangiomas or haemangio-sarcomas
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of various sites, and 32-miscellaneous benign nor malignant neoplasms. These
105 different tumours were distributed seemingly at random through the 16
groups. In so far as most ofthese tumours were incidental findings at necropsy,
and not causes of death, and in so far as many of them were benign and/or slow
growing, the incidence rates are not susceptible to actuarial analysis.
DISCUSSION
In our study of the induction of malignant skin tumours by the regular appli-
cation of carcinogens to mouse skin, we have found an approximately linear dose/
response curve for NF, and a definitely non-linear dose/response curve for BP.
We also found that combinations of NF and BP together gave a higher incidence
rate than the sum of the incidence rates that they would have produced alone.
Carcinogenesis is known to be a multi-stage process, and these findings suggest
that NF acts mainly on only one rate-determining stage of the carcinogenic
process whereas BP acts on more than one such stage.
The existence of a carcinogen-cocarcinogen interaction means that PAH in
the inhuman environment at concentrations which are themselves subcarcinogenic
might nevertheless be dangerous in the presence of other agents, particularly
tobacco smoke.
For the purposes of analysing the results of the experiments reported, new
statistical techniques based on actuarial analysis have been developed. The
advantages-indeed the necessity-for using actuarial methods for analysing the
results ofsurvival experiments (i.e. most animals are still alive and well) is clearly
exemplified in this paper. Our experience with these techniques also illustrates
the limitation of actuarial analysis in that it cannot be applied to non-lethal
slow-growing internal neoplasms, the presence of which is not reliably detectable
until post mortem. Comparison of incidences of this class of neoplasm must be
based on findings in killings of random samples of groups of animals.
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